Literature DB >> 14616454

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study.

P Boyle1, C Robertson, C Mazzetta, M Keech, R Hobbs, R Fourcade, L Kiemeney, C Lee.   

Abstract

OBJECTIVE: To report a large-scale multinational investigation of lower urinary tract symptoms (LUTS) and sexual function, designed to investigate the independent association between them, as recent small-scale epidemiological studies suggest an association between benign prostatic hyperplasia and sexual dysfunction; both conditions are strongly associated with age and no study has been able to exclude age as a confounding factor in this relationship. SUBJECTS AND METHODS: Culturally and linguistically validated versions of standard questionnaires were used to estimate the prevalence of LUTS (using the International Prostate Symptom Score, IPSS) and erectile dysfunction (ED) score (using O'Leary's Sexual Function Inventory) in regions of the UK (Birmingham), the Netherlands (Boxmeer), France (Auxerre) and Korea (Seoul). In each centre, stratified random samples were selected from population registers to provide representative samples of the population of men aged 40-79 years (and their partners) in each community. Direct interviews were held in Seoul and postal questionnaires used in the three European centres. The samples were selected randomly, providing representative samples in each community.
RESULTS: In all, 4800 men and 3674 women responded; the response rates among men were 77% in Boxmeer, 21% in Auxerre, 42% in Birmingham and 65% in Seoul. The overall prevalence of ED for men aged 40-79, estimated as an ED score of 0-4, was 21.1%. There was evidence of a linear increase with age (P < 0.001) and the pattern was very similar in the four centres. From the weighted logistic model, there was evidence of an association between sexual dysfunction, other self-reported diseases and lifestyle. From the ED score, after adjusting for age and country, men with diabetes were more likely to score of 0-4 (odds ratio 1.57, 95% confidence interval 1.09-2.25), as were those with high blood pressure (1.38, 1.09-1.75) and with an IPSS of 8-35 (1.39, 1.10-1.74). For lifestyle, smokers were more likely to score 0-4 (1.54, 1.23-1.92), while physical activity during leisure time was slightly associated with a reduction in the chance of scoring 0-4 (0.87, 0.77-0.99). The analysis gave the same results when repeated using self-reported ED instead of the dichotomised score.
CONCLUSIONS: ED is clearly age-related and a problem for a large proportion of men in the community. It can have a profound impact on the quality of life of the man and on his partner. Were all men with this problem to seek medical help there would be a large burden on healthcare systems. There are cultural and age effects on the assessment of this problem.

Entities:  

Mesh:

Year:  2003        PMID: 14616454     DOI: 10.1046/j.1464-410x.2003.04459.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  26 in total

Review 1.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 2.  Risk factors for benign prostatic hyperplasia.

Authors:  Steven J Jacobsen
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 3.  Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS.

Authors:  Selim Cellek; Norman E Cameron; Mary A Cotter; Christopher H Fry; Dapo Ilo
Journal:  Nat Rev Urol       Date:  2014-03-11       Impact factor: 14.432

4.  Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries.

Authors:  John P Mulhall; Tarek A Hassan; James Rienow
Journal:  Int J Clin Pract       Date:  2018-02-20       Impact factor: 2.503

5.  Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study.

Authors:  I A Korneyev; T A Alexeeva; S H Al-Shukri; A N Bernikov; A A Erkovich; A A Kamalov; M I Kogan; V N Pavlov; V N Zhuravlev; D Y Pushkar
Journal:  Int J Impot Res       Date:  2016-02-11       Impact factor: 2.896

6.  Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.

Authors:  Naomi M Gades; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Michael M Lieber; Ajay Nehra; Cynthia J Girman; Steven J Jacobsen
Journal:  J Sex Med       Date:  2009-06-29       Impact factor: 3.802

7.  Prostatic profile, premature ejaculation, erectile function and andropause in an at-risk Mexican population.

Authors:  J Jaspersen-Gastelum; J A Rodríguez; F J Espinosa de los Monteros; L Beas-Sandoval; José Guzmán-Esquivel; D D Calvo; T Gutiérrez
Journal:  Int Urol Nephrol       Date:  2008-07-15       Impact factor: 2.370

Review 8.  A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.

Authors:  Konstantinos Hatzimouratidis
Journal:  Ther Adv Urol       Date:  2014-08

9.  A prospective study of lower urinary tract symptoms and erectile dysfunction.

Authors:  Alison M Mondul; Eric B Rimm; Edward Giovannucci; Dale B Glasser; Elizabeth A Platz
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

10.  The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH.

Authors:  Asim Ozayar; Ali Ersin Zumrutbas; Onder Yaman
Journal:  Int Urol Nephrol       Date:  2008-04-24       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.